A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607

NCT02737007 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria, Falciparum

Interventions

DRUG: [14C]-GSK3191607

Sponsor

GlaxoSmithKline

Collaborators

[object Object]